Press releases //

IntegraGen reports 6.4 M€ in revenues for the first half of 2022 representing 34% growth compared to H1 2021. Cash position of 4.5 M€.

Chiffre affaires en croissance pour IntegraGen - Premier semestre 2021
Continued sustained growth associated with the company’s sequencing platform in Évry and long-term contracts Strong revenue growth linked with microbiology sequencing

Evry, France, Wednesday July 13th 2022, 7.30am – IntegraGen (FR0010908723 – ALINT ), an OncoDNA Group company specializing in the decryption of the human genome which performs (…)  » 

News //

New Look. New Portfolio. New Opportunities.

Outsmart molecular complexity - OncoDNA group
Following its acquisition by OncoDNA, IntegraGen has been given a brand new look and is ready to take on new projects in the fields of cancer and genetic diseases.

Since the successful takeover in November 2020, IntegraGen has been working hand in hand with OncoDNA (…)  »